Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer
Sebastian Marwitz(Research Center Borstel - Leibniz Lung Center), Bernard A. Fox(Oregon Health & Science University)
Cited by 26
Related Papers
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers
|Clinical Cancer Research|2011|109
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response
|Journal for ImmunoTherapy of Cancer|2020|93
The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC
|Frontiers in Oncology|2020|40